Virtus Wealth Solutions’s Amneal Pharmaceuticals AMRX Stock Holding History

Virtus Wealth Solutions’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.21M	Buy	+159,140	New	+$2.87M	0.54%	23

Other funds holding AMRX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Tucker Asset Management Littleton, Colorado $406M AUM 20.49% 1-Year Est. Return

Quartz Partners Saratoga Springs, New York $330M AUM 17.57% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Signature Wealth Management Partners Montvale, New Jersey $234M AUM 23.06% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Virtus Wealth Solutions's AMRX Position: Q3 2026 in Review

Virtus Wealth Solutions opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 159,140 shares worth $3.21M. The stake represents 0.54% of the portfolio and ranks #23 among its holdings.

110 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

Virtus Wealth Solutions held 159,140 shares of Amneal Pharmaceuticals worth $3.21M as of Q3 2026.
Amneal Pharmaceuticals was a new Virtus Wealth Solutions position in Q3 2026.
Amneal Pharmaceuticals made up 0.54% of Virtus Wealth Solutions's portfolio in Q3 2026, its #23 holding.
110 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Virtus Wealth Solutions's 13F filing for Q3 2026, filed 3 Nov 2026.